Harvard 5th Annual Update in Neuro-Oncology 2025

$65

Description

Product Overview & Details for Harvard 5th Annual Update in Neuro-Oncology 2025

Videos+PDFs

5th Annual Update in Neuro-Oncology

Overview

Neuro-oncology is a rapidly evolving multi-disciplinary field, which involves the medical, radiation, and surgical management of pediatric and adult patients with primary and metastatic tumors of the central nervous system (CNS) and peripheral nervous system (PNS). The field of neuro-oncology also encompasses neurogenetic syndromes, like neurofibromatosis, associated with nervous system tumors and various neurological complications of cancer and cancer treatments. In addition, modern molecular neuropathology and neuroradiology concepts are essential for accurate diagnosis and classification.

This three-day CME course, the 5th Annual Update in Neuro-Oncology, is designed to provide an international audience with a comprehensive review of the diagnosis and management of pediatric and adult patients with primary and metastatic CNS and PNS tumors, specific neurogenetic syndromes, and neurological complications of cancer.

The target audience consists of providers and trainees involved in the care of adult and pediatric neuro-oncology patients (neurologists, oncologists, radiation oncologists, neurosurgeons, neurologists, neuroradiologists, and neuropathologists). The course will also be of high relevance to nurse practitioners, physician assistants, psychologists, pharmacists, nurses, and industry professionals.

Learning Objectives

  • Define the role of molecular biomarkers in the accurate diagnosis and classification of pediatric and adult CNS and PNS tumors.
  • Determine standard and novel treatment approaches to pediatric and adult CNS and PNS tumors.
  • Recognize and manage neurological complications associated with new cancer therapies.
  • Describe and manage long-term complications of CNS and PNS tumors and their treatment.
Day Topic Speaker
Day 1 – Wednesday, July 23, 2025 Opening Remarks: Pediatric Neuro-Oncology Session Lissa Baird
WHO Classification, Pediatric CNS Tumors Sanda Alexandrescu
Advances in the Imaging of Pediatric Brain Tumors Tina Young Poussaint
Embryonal Tumors Susan Chi
Pediatric Low-Grade Gliomas Pratiti Bandopadhayay
Break
Pediatric High-Grade Gliomas Mariella Filbin
Ependymomas Karen Wright
Live Question and Answer Session Lissa Baird
Break
Choroid Plexus Tumors Viviana Benitez
Pineal Tumors Shannon MacDonald
Germ Cell Tumors Kee Kiat Yeo
Neurofibromatosis and Schwannomatosis Justin Jordan
Von Hippel Lindau Othon Iliopoulos
Live Question and Answer Session Lissa Baird
Live CNS Tumor Board Mariella Filbin; Ralph Salloum
Adjourn
Day 2 – Thursday, July 24, 2025 Welcome: Adult Neuro-Oncology Tracy Batchelor
Advances in Surgery for Brain Tumors E. Antonio Chiocca
Advances in the Imaging of Adult Brain Tumors Raymond Huang
Advances in Radiation for Brain Tumors Ariel Marciscano
WHO Classification for Adult Gliomas Maria Martinez-Lage Alvarez
Live Question and Answer Session Tracy Batchelor
Break
Gliomas, IDH-Mutant L. Nicolas Gonzalez Castro
Gliomas, IDH-Wildtype Isabel Arrillaga-Romany
Advances in Experimental Therapies for Gliomas David Reardon
Live CNS Tumor Board L. Nicolas Gonzalez Castro
Break
Meningiomas Wenya Linda Bi
CNS lymphomas Tracy Batchelor
Pituitary Tumors Pamela Jones
Live Question and Answer Session L. Nicolas Gonzalez Castro
Adjourn
Day 3 – Friday, July 25, 2025 Welcome: Neurological Complications of Cancer Patrick Wen
Metastases to the Brain Priscilla Brastianos
Metastases to the Leptomeninges Nancy Wang
Metastases to the Epidural Space and Spinal Cord John Chi
Paraneoplastic Neurological Syndromes David Gritsch
Live Question and Answer Session Patrick Wen
Break
Common Neurological Complications in Cancer Patients Julie Miller
Neurological Complications of Cancer Immunotherapies Jorg Dietrich
Survivorship of CNS tumors Deborah Forst
Live Question and Answer Session Patrick Wen
Live CNS Tumor Board Annie Hsieh
Closing Statements Tracy Batchelor
Categories: , , , Tags: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,